Triazole compounds and the therapeutic use thereof

US7465744B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Dorothea Starck · Ludwigshafen, DE
• Hans-Jörg Treiber · Münstermaifeld, DE
• Thomas Zierke · Böhl-Iggelheim, DE
• Georg Kettschau · Berlin, DE
• Hervé Geneste · Schifferstadt, DE
• Andreas Haupt · Ludwigshafen, DE
• Liliane Unger · Ludwigshafen, DE
• Kai Blumbach · Steinen, DE
• Dietmar Schöbel · Mannheim, DE
• Hans-Jurgen Teschendorf · Dudenhofen, DE

Key dates

• Filing date: Feb 5, 2004
• Grant date: Dec 16, 2008
• Expiry date: Feb 5, 2024

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/14
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The invention relates to triazole compounds of general formula (I), wherein A, B, R1, R2, R3 and R4 have the meaning cited in claim 1. The invention also relates to a pharmaceutical agent containing at least one compound of general formula (I) in addition to the use of the compound (I) for producing a pharmaceutical agent for treating illnesses, responding to the effects of dopamine-D3-receptor antagonists or dopamine-D3-receptor agonists, especially for treating disorders in the central nervous system.